Question: Please describe this drug.
Description: The Chemical can be represented with the SMILES COCCOCCCC(=O)NCCCC[C@H](N)C(=O)O.
Answer: Pegvorhyaluronidase alfa is under investigation in clinical trial NCT02241187 (Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection).
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
COCCOCCCC(=O)NCCCC[C@H](N)C(=O)O
COCCOCCCC(=O)NCCCC[C@@H](C(=O)O)N
(2S)-2-amino-6-[4-(2-methoxyethoxy)butanoylamino]hexanoicacid
Please describe this drug.
Pegvorhyaluronidase alfa is under investigation in clinical trial NCT02241187 (Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection).